Your Flagship ADC Event in Europe
Your Preliminary Agenda Is Here - View It Now

Speakers

Expert Speaker Faculty Spanning Europe, North America & Asia

Take a look at the esteemed speaker faculty for the 17th World ADC London Summit.

Alireza Tafazzol

Senior Scientist
AbbVie

Alan Russell

Vice President, Research & Head, R&D Technology & Innovation
Amgen

Dragan Grabulovski

Chief Executive Officer
Araris Biotech

David Illescas

Clinical Investigator
Arrixaca University Hospital

Elena de Orbe

Associate Principal, Computational Chemist
AstraZeneca

Tingting Cui

Associate Director
AstraZeneca

Osama Charhrour

Principal Scientist - New Modalities
AstraZeneca

Yu-Shin Hsu

Senior Research Analyst
Beacon Intelligence

Javad Shahidi

Senior Vice President, Head of Biotech Unit & Development Innovation
BeOne Medicines

Rakesh Dixit

President & Chief Executive Officer
Bionavigen Oncology

Yuan-An (Angus) Liu

Director Protein & ADC Drug Product
BioNTech

Evelyn Fahrenkrug

Global Commercial Head Oncology Pipeline
Boehringer Ingelheim

Wim Dokter

Chief Scientific Officer
Byondis

Jeremy Sauer

Vice President, Strategy
Callio Therapeutics

Charles Dumontet

Deputy Director & Investigator
Cancer Research Centre of Lyon

Giorgio Massimini

Chief Medical Officer
CanWell Pharma

Hong Zebger-Gong

Senior Medical Director, Global Oncology Clinical Development
Daiichi Sankyo

Leo Marx

Head of ADC Research & Technologies
Debiopharm

Jesús Fuentes Antrás

Medical Oncologist & Clinical Investigator
Hospital Universitario Quirónsalud Madrid

Jerome Boyd-Kirkup

Chief Scientific Officer & Co-Founder
Hummingbird Bioscience

Dave Simpson

Chief Executive Officer
Iksuda Therapeutics

Robert Lutz

Chief Scientific Officer
Iksuda Therapeutics

Scott Lesley

President & Chief Scientific Officer
InduPro

Min Hu

Senior Vice President, Oncology Discovery
Innovent Biologics

Kurt Pike

Senior Director, Discovery Product Development & Supply (DPDS) External Innovation
Johnson & Johnson

Eugenio Cardenal Virgil

Associate Director Regulatory Affiars CMC
Johnson & Johnson

Matthew Sender

Director & ADC Project Lead
LigaChem Biosciences

Mike Seganish

Distinguished Scientist & Executive Director, Scientific Discovery
Merck & Co

Robert Andrews

ADC & Conjugate Patent Strategy (European Patent Attorney)
Mewburn Ellis LLP

Valerie Vanhooren

Chief Executive Office
Ona Therapeutics

Christian Rohlff

Chief Executive Officer
Oxford Biotherapeutics

Kevin Hamblett

Senior Director, ADC Pharmcology
Pfizer

Alain Beck

Senior Director, Biologics CMC Developabilit
Pierre Fabre

Nicola Beltraminelli

ADC Bioprocess Expert
Pierre Fabre

John Lambert

Consultant & Honorary Professor
Queen's University Belfast

Floriana Cremasco

Senior Scientist
Roche

Ines Grazina de Matos

Principal Scientist
Roche

Samuel Murphy

Chief Executive Officer
Salubris Biotherapeutics

Marc Robillard

Co-Founder & Chief Scientific Officer
Tagworks Pharmaceuticals

Harold Keer

Chief Medical Officer
Taiho Oncology

Greg Thurber

Professor, Chemical & Biomedical Engineering
University of Michigan

Ali Salanti

Co-Founder & Chief Executive Officer
VAR2 Pharmaceuticals

Tobias Gustavson

Senior Director, Bioconjugation & CMC
VAR2 Pharmaceuticals

ADC-720_1_11zon

Explore the Preliminary Agenda

Hear the latest industry insights and discover cutting-edge, end-to-end ADC content from early discovery to late-stage manufacturing.

View the Presentations & Speakers

ADC-267_4_11zon

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Explore Sponsorship Options

ADC-055_7_11zon

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.